Category: Health & Medicines > Medicines > Ciprofloxacin Tablets
Country/Region: China State/Province: Hebei
Main Products: MAEM, TTZ, ATMAA, Ceftriaxone, Cefotaxime, Cefazolin
Business Type: Exporter, Retailer
Year Established: 2007
Employees: 5 - 10 People
Plant Area: Above 100,000 square meters
Main Markets: South America 11% Africa 9% Eastern Asia 8% Domestic Market 12% North America 9% Eastern Europe 8% Southern Europe 9% Mid East 9% Northern Europe 10% Oceania 15%
Trade Capacity: FOB, FCA, DDU
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Shijiazhuang
Annual Revenue: US$5 Million - US$10 Million
Total Revenue: US$10 Million - US$50 Million
Export Revenue: US$10 Million - US$50 Million
Annual Output: Above US$100 Million
Registered Capital: Below US$1 Million
Export Percentage: 21% - 30%
Payment Modes: USD, EUR, GBP
Lead Time: 28 days
Import/Export Mode: LLC (Limited Liability Corp)